Qing-qing Zhang1, Wen-juan Wang1, Jun Li1, Neng Yang1, Gang Chen2, Zhong Wang2, Zhong-qin Liang1. 1. Department of Pharmacology, College of Pharmaceutical Sciences, Soochow University, Suzhou 215000, China. 2. Department of Neurosurgery, The First Affiliated Hospital of Soochow University, Suzhou 215000, China.
Abstract
AIM: Cathepsin L is a lysosomal cysteine protease that plays important roles in cancer tumorigenesis, proliferation and chemotherapy resistance. The aim of this study was to determine how cathepsin L regulated the radiosensitivity of human glioma cells in vitro. METHODS: Human glioma U251 cells (harboring the mutant type p53 gene) and U87 cells (harboring the wide type p53 gene) were irradiated with X-rays. The expression of cathepsin L was analyzed using Western blot and immunofluorescence assays. Cell survival and DNA damage were evaluated using clonogenic and comet assays, respectively. Flow cytometry was used to detect the cell cycle distribution. Apoptotic cells were observed using Hoechst 33258 staining and fluorescence microscopy. RESULTS: Irradiation significantly increased the cytoplasmic and nuclear levels of cathepsin L in U251 cells but not in U87 cells. Treatment with the specific cathepsin L inhibitor Z-FY-CHO (10 μmol/L) or transfection with cathepsin L shRNA significantly increased the radiosensitivity of U251 cells. Both suppression and knockdown of cathepsin L in U251 cells increased irradiation-induced DNA damage and G2/M phase cell cycle arrest. Both suppression and knockdown of cathepsin L in U251 cells also increased irradiation-induced apoptosis, as shown by the increased levels of Bax and decreased levels of Bcl-2. CONCLUSION: Cathepsin L is involved in modulation of radiosensitivity in human glioma U251 cells (harboring the mutant type p53 gene) in vitro.
AIM: Cathepsin L is a lysosomal cysteine protease that plays important roles in cancer tumorigenesis, proliferation and chemotherapy resistance. The aim of this study was to determine how cathepsin L regulated the radiosensitivity of humanglioma cells in vitro. METHODS:Humanglioma U251 cells (harboring the mutant type p53 gene) and U87 cells (harboring the wide type p53 gene) were irradiated with X-rays. The expression of cathepsin L was analyzed using Western blot and immunofluorescence assays. Cell survival and DNA damage were evaluated using clonogenic and comet assays, respectively. Flow cytometry was used to detect the cell cycle distribution. Apoptotic cells were observed using Hoechst 33258 staining and fluorescence microscopy. RESULTS: Irradiation significantly increased the cytoplasmic and nuclear levels of cathepsin L in U251 cells but not in U87 cells. Treatment with the specific cathepsin L inhibitor Z-FY-CHO (10 μmol/L) or transfection with cathepsin L shRNA significantly increased the radiosensitivity of U251 cells. Both suppression and knockdown of cathepsin L in U251 cells increased irradiation-induced DNA damage and G2/M phase cell cycle arrest. Both suppression and knockdown of cathepsin L in U251 cells also increased irradiation-induced apoptosis, as shown by the increased levels of Bax and decreased levels of Bcl-2. CONCLUSION:Cathepsin L is involved in modulation of radiosensitivity in humanglioma U251 cells (harboring the mutant type p53 gene) in vitro.
Authors: K Fujimoto; R Hosotani; R Doi; M Wada; J U Lee; T Koshiba; Y Miyamoto; S Tsuji; S Nakajima; M Imamura Journal: Int J Cancer Date: 1999-05-17 Impact factor: 7.396
Authors: Jacqueline M Lankelma; Daniëlle M Voorend; Temo Barwari; Joris Koetsveld; Anne H Van der Spek; Alexander P N A De Porto; Geeske Van Rooijen; Cornelis J F Van Noorden Journal: Life Sci Date: 2009-11-30 Impact factor: 5.037
Authors: Y Hu; W Ouyang; F Wu; C H Cao; K Wang; Z K Liao; Y H Zhong; F X Zhou; S Q Liu; L Xia; Y F Zhou; C H Xie Journal: Oncol Rep Date: 2009-10 Impact factor: 3.906
Authors: Surinder M Soond; Lyudmila V Savvateeva; Vladimir A Makarov; Neonila V Gorokhovets; Paul A Townsend; Andrey A Zamyatnin Journal: Cancers (Basel) Date: 2020-11-22 Impact factor: 6.639
Authors: Surinder M Soond; Lyudmila V Savvateeva; Vladimir A Makarov; Neonila V Gorokhovets; Paul A Townsend; Andrey A Zamyatnin Journal: Pharmaceutics Date: 2021-03-05 Impact factor: 6.321